参考文献:1.Kaufman DW, Kelly JP, Rosenberg L et al (2002) Recent patterns of medication used in the ambulatory adult population of the United States: the Slone survey. JAMA 28:7337–7344 2.Trelle S, Reichenbach S, Wandel S et al (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342:c7086PubMedCentral CrossRef PubMed 3.Ungprasert P, Srivali N, Wijarnpreecha K et al (2015) Non-steroidal anti inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis. Rheumatology 54(4):736–742CrossRef PubMed 4.Brooks Peter M, Day Richard O (1991) Non steroidal antiinflammatory drugs-differences and similarities. New Engl J Med 324:1716–1725CrossRef
1. Internal Medicine, Coagulation Section, Cardiovascular Science Department, Padua University, Via Giustiniani, 2, 35128, Padua, Italy 2. Internal Medicine Department (DIMED), Radiology Institute, Padua University, Padua, Italy
刊物主题:Geriatrics/Gerontology;
出版者:Springer International Publishing
ISSN:1720-8319
文摘
Non-steroidal anti-inflammatory drugs have been associated with an increased risk of venous thromboembolism. We report for the first time, the case of a patient who developed massive pulmonary embolism after a long period of treatment with high doses of ibuprofen. A 65-year-old woman was admitted with severe dyspnea while on treatment with high doses of ibuprofen for diffuse spine pain due to arthrosis. A spiral computed tomography showed a massive pulmonary embolism. No other explanation for the thromboembolic disorder was found. She was successfully treated with therapeutic doses of low-molecular-weight heparin followed by rivaroxaban. Ibuprofen was discontinued and replaced by tramadol. High-dose ibuprofen is likely to have accounted for the life-threatening thromboembolic disorder. Keywords Non-steroidal anti-inflammatory Venous thromboembolism Pulmonary embolism Ibuprofen Adverse effects